Health
BioNTech Stock Pops Ahead Of Earnings; But Can Its Vaccine Tackle Delta? – Investor’s Business Daily
BioNTech stock popped Monday after the Covid-vaccine maker said it would announce second-quarter earnings results in a week.
BioNTech stock popped Monday after the Covid vaccine maker said it would announce second-quarter earnings results in a week.
XAnalysts polled by FactSet expect BioNTech (BNTX) to report adjusted earnings of $8.94 per share and almost $3.86 billion in sales….
Continue Reading
-
Noosa News24 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News22 hours agoMan dies in Gold Coast after rolling trailer pins him to lamp-post
-
General22 hours agoDairy farmers devastated by floods across parts of New South Wales
-
Noosa News19 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project